<DOC>
	<DOCNO>NCT02128581</DOCNO>
	<brief_summary>Exendin- ( 9,39 ) show effect beta-cell function , gastric bypass , accelerate gastrointestinal transit . - infused rate 300pmol/kg/min . Given gastrointestinal transit typically delay Glucagon-Like Peptide-1 ( GLP-1 ) also hormone cause decrease food intake increase satiation , reasonable expect effect Exendin-9,39 appetite . This may help explain effect gastric bypass food intake . To examine effect Exendin food intake propose dose-response study determine whether compound effect dose-dependent fashion . We examine presence gastrointestinal symptom well food intake immediate aftermath test meal subsequent hour .</brief_summary>
	<brief_title>A Dose-response Effects Exendin-9,39 GI Symptoms Food Intake</brief_title>
	<detailed_description />
	<criteria>Subjects undergone Roux enY Gastric Bypass least 6 month prior enrollment study . Subjects without active systemic illness . Subjects &lt; 20 year age study minimize possibility type 1 diabetes . Subjects &gt; 70 year age study minimize potential confounding effect age glucose tolerance .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>